Beyond HLA-A*0201: New HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8 + T cell epitopes

Zoltan Antal, Jason C. Baker, Carla Smith, Irene Jarchum, Jeffrey Babad, Gayatri Mukherjee, Yang Yang, John Sidney, Alessandro Sette, Pere Santamaria, Teresa P. DiLorenzo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Type 1 diabetes is an autoimmune disease characterized by T cell responses to β cell Ags, including insulin. Investigations employing the NOD mouse model of the disease have revealed an essential role for β cell-specific CD8 + T cells in the pathogenic process. As CD8 + T cells specific for β cell Ags are also present in patients, these reactivities have the potential to serve as therapeutic targets or markers for autoimmune activity. NOD mice transgenic for human class I MHC molecules have previously been employed to identify T cell epitopes having important relevance to the human disease. However, most studies have focused exclusively on HLA-A*0201. To broaden the reach of epitope-based monitoring and therapeutic strategies, we have looked beyond this allele and developed NOD mice expressing human β 2-microglobulin and HLA-A*1101 or HLA-B*0702, which are representative members of the A3 and B7 HLA supertypes, respectively. We have used islet-infiltrating T cells spontaneously arising in these strains to identify b cell peptides recognized in the context of the transgenic HLA molecules. This work has identified the insulin C-peptide as an abundant source of CD8 + T cell epitopes. Responses to these epitopes should be of considerable utility for immune monitoring, as they cannot reflect an immune reaction to exogenously administered insulin, which lacks the C-peptide. Because the peptides bound by one supertype member were found to bind certain other members also, the epitopes identified in this study have the potential to result in therapeutic and monitoring tools applicable to large numbers of patients and at-risk individuals.

Original languageEnglish (US)
Pages (from-to)5766-5775
Number of pages10
JournalJournal of Immunology
Volume188
Issue number11
DOIs
StatePublished - Jun 1 2012

Fingerprint

Inbred NOD Mouse
T-Lymphocyte Epitopes
C-Peptide
Type 1 Diabetes Mellitus
Transgenic Mice
Insulin
T-Lymphocytes
Epitopes
HLA-A3 Antigen
HLA-B7 Antigen
Immunologic Monitoring
Peptides
HLA-A Antigens
Autoimmune Diseases
Therapeutics
Alleles
HLA-A*02:01 antigen

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Beyond HLA-A*0201 : New HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8 + T cell epitopes. / Antal, Zoltan; Baker, Jason C.; Smith, Carla; Jarchum, Irene; Babad, Jeffrey; Mukherjee, Gayatri; Yang, Yang; Sidney, John; Sette, Alessandro; Santamaria, Pere; DiLorenzo, Teresa P.

In: Journal of Immunology, Vol. 188, No. 11, 01.06.2012, p. 5766-5775.

Research output: Contribution to journalArticle

Antal, Zoltan ; Baker, Jason C. ; Smith, Carla ; Jarchum, Irene ; Babad, Jeffrey ; Mukherjee, Gayatri ; Yang, Yang ; Sidney, John ; Sette, Alessandro ; Santamaria, Pere ; DiLorenzo, Teresa P. / Beyond HLA-A*0201 : New HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8 + T cell epitopes. In: Journal of Immunology. 2012 ; Vol. 188, No. 11. pp. 5766-5775.
@article{28d199443db240f4b0a795e341cd5ae6,
title = "Beyond HLA-A*0201: New HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8 + T cell epitopes",
abstract = "Type 1 diabetes is an autoimmune disease characterized by T cell responses to β cell Ags, including insulin. Investigations employing the NOD mouse model of the disease have revealed an essential role for β cell-specific CD8 + T cells in the pathogenic process. As CD8 + T cells specific for β cell Ags are also present in patients, these reactivities have the potential to serve as therapeutic targets or markers for autoimmune activity. NOD mice transgenic for human class I MHC molecules have previously been employed to identify T cell epitopes having important relevance to the human disease. However, most studies have focused exclusively on HLA-A*0201. To broaden the reach of epitope-based monitoring and therapeutic strategies, we have looked beyond this allele and developed NOD mice expressing human β 2-microglobulin and HLA-A*1101 or HLA-B*0702, which are representative members of the A3 and B7 HLA supertypes, respectively. We have used islet-infiltrating T cells spontaneously arising in these strains to identify b cell peptides recognized in the context of the transgenic HLA molecules. This work has identified the insulin C-peptide as an abundant source of CD8 + T cell epitopes. Responses to these epitopes should be of considerable utility for immune monitoring, as they cannot reflect an immune reaction to exogenously administered insulin, which lacks the C-peptide. Because the peptides bound by one supertype member were found to bind certain other members also, the epitopes identified in this study have the potential to result in therapeutic and monitoring tools applicable to large numbers of patients and at-risk individuals.",
author = "Zoltan Antal and Baker, {Jason C.} and Carla Smith and Irene Jarchum and Jeffrey Babad and Gayatri Mukherjee and Yang Yang and John Sidney and Alessandro Sette and Pere Santamaria and DiLorenzo, {Teresa P.}",
year = "2012",
month = "6",
day = "1",
doi = "10.4049/jimmunol.1102930",
language = "English (US)",
volume = "188",
pages = "5766--5775",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Beyond HLA-A*0201

T2 - New HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8 + T cell epitopes

AU - Antal, Zoltan

AU - Baker, Jason C.

AU - Smith, Carla

AU - Jarchum, Irene

AU - Babad, Jeffrey

AU - Mukherjee, Gayatri

AU - Yang, Yang

AU - Sidney, John

AU - Sette, Alessandro

AU - Santamaria, Pere

AU - DiLorenzo, Teresa P.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Type 1 diabetes is an autoimmune disease characterized by T cell responses to β cell Ags, including insulin. Investigations employing the NOD mouse model of the disease have revealed an essential role for β cell-specific CD8 + T cells in the pathogenic process. As CD8 + T cells specific for β cell Ags are also present in patients, these reactivities have the potential to serve as therapeutic targets or markers for autoimmune activity. NOD mice transgenic for human class I MHC molecules have previously been employed to identify T cell epitopes having important relevance to the human disease. However, most studies have focused exclusively on HLA-A*0201. To broaden the reach of epitope-based monitoring and therapeutic strategies, we have looked beyond this allele and developed NOD mice expressing human β 2-microglobulin and HLA-A*1101 or HLA-B*0702, which are representative members of the A3 and B7 HLA supertypes, respectively. We have used islet-infiltrating T cells spontaneously arising in these strains to identify b cell peptides recognized in the context of the transgenic HLA molecules. This work has identified the insulin C-peptide as an abundant source of CD8 + T cell epitopes. Responses to these epitopes should be of considerable utility for immune monitoring, as they cannot reflect an immune reaction to exogenously administered insulin, which lacks the C-peptide. Because the peptides bound by one supertype member were found to bind certain other members also, the epitopes identified in this study have the potential to result in therapeutic and monitoring tools applicable to large numbers of patients and at-risk individuals.

AB - Type 1 diabetes is an autoimmune disease characterized by T cell responses to β cell Ags, including insulin. Investigations employing the NOD mouse model of the disease have revealed an essential role for β cell-specific CD8 + T cells in the pathogenic process. As CD8 + T cells specific for β cell Ags are also present in patients, these reactivities have the potential to serve as therapeutic targets or markers for autoimmune activity. NOD mice transgenic for human class I MHC molecules have previously been employed to identify T cell epitopes having important relevance to the human disease. However, most studies have focused exclusively on HLA-A*0201. To broaden the reach of epitope-based monitoring and therapeutic strategies, we have looked beyond this allele and developed NOD mice expressing human β 2-microglobulin and HLA-A*1101 or HLA-B*0702, which are representative members of the A3 and B7 HLA supertypes, respectively. We have used islet-infiltrating T cells spontaneously arising in these strains to identify b cell peptides recognized in the context of the transgenic HLA molecules. This work has identified the insulin C-peptide as an abundant source of CD8 + T cell epitopes. Responses to these epitopes should be of considerable utility for immune monitoring, as they cannot reflect an immune reaction to exogenously administered insulin, which lacks the C-peptide. Because the peptides bound by one supertype member were found to bind certain other members also, the epitopes identified in this study have the potential to result in therapeutic and monitoring tools applicable to large numbers of patients and at-risk individuals.

UR - http://www.scopus.com/inward/record.url?scp=84862106232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862106232&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1102930

DO - 10.4049/jimmunol.1102930

M3 - Article

C2 - 22539795

AN - SCOPUS:84862106232

VL - 188

SP - 5766

EP - 5775

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -